Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
Introduction: Iron overload is the primary cause of mortality and morbidity in thalassemia major (TM) despite advances in chelation therapy. The aim of this study was to compare the effectiveness and safety of deferasirox (DFX) and deferoxamine (DFO) as iron-chelating agents in patients with trans...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Electronic Physician
2016-05-01
|
| Col·lecció: | Electronic Physician |
| Matèries: | |
| Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930264/ |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|